热门资讯> 正文
2025-03-03 21:46
OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports results on March 5 (estimated) for the period ending December 31 2024
The Yardley Pennsylvania-based company is expected to report a 12.3% increase in revenue to $22.307 million from $19.87 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $23.00 million.
LSEG's mean analyst estimate for OptiNose Inc is for a loss of 72 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OptiNose Inc is $17.50, above its last closing price of $5.81.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING |
STARMINESMARTESTIMATE® |
LSEG IBES ESTIMATE |
ACTUAL |
BEAT, MET, MISSED |
SURPRISE % |
Sep. 30 2024 |
-0.79 |
-0.79 |
0.00 |
Beat |
100 |
Jun. 30 2024 |
-1.11 |
-1.16 |
-0.75 |
Beat |
35.3 |
Mar. 31 2024 |
-1.63 |
-1.61 |
-1.80 |
Missed |
-11.6 |
Dec. 31 2023 |
-1.42 |
-1.41 |
-1.35 |
Beat |
4.6 |
Sep. 30 2023 |
-1.42 |
-1.41 |
-1.20 |
Beat |
15.2 |
Jun. 30 2023 |
-1.61 |
-1.63 |
0.30 |
Beat |
118.4 |
Mar. 31 2023 |
-2.06 |
-2.09 |
-2.55 |
Missed |
-22 |
Dec. 31 2022 |
-2.60 |
-2.62 |
-2.55 |
Beat |
2.7 |
This summary was machine generated March 3 at 13:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)